Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Additional Ventures is a US-headquartered non-profit公益 organization whose core mission is to ultimately achieve a cure for single-ventricle congenital heart disease through funding research and advancing academic collaboration. The website serves two core user groups: for researchers working on single-ventricle heart disease, it offers research grant application and academic collaboration matching services; for single-ventricle heart disease patients and their families, it provides updates on the latest disease research progress.
To date, the organization has committed more than $95 million to fund relevant research, supported over 200 research projects, and enabled funded researchers to publish 125 academic papers. It also regularly hosts the Single Ventricle Investigators Meeting (SVIM) to foster exchange and collaboration within the field, and recently launched a translation acceleration program to move research findings toward clinical application. It is a highly influential public funding body in the single-ventricle heart disease research space.
On the plus side, the organization has a clear, focused mission, directing all of its resources to this niche rare disease area of single-ventricle heart disease. Its funding mechanism is flexible, effectively accelerating research progress in the field, and all information is open and transparent — the public can check project updates at any time. The downsides are that it only provides research funding and does not offer direct medical financial assistance to patients. It also has no Chinese language support, which creates a high barrier for general users in China.
The website is currently directly accessible via the public internet in China, no proxy tool is required. Pages load normally, and all core business information is clearly readable. It is a great resource for researchers working on congenital heart disease in China to follow for grant opportunities, and for family members of affected patients to learn about the latest cutting-edge progress in the field.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on additionalventures.org official site.
additionalventures.org is an United States Nonprofit provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach additionalventures.org directly.